We are laser-focused on our mission: to improve the lives of patients and their families.

Clinical Trials

Our pipeline programs target kidney diseases of high unmet need: ADPKD and Alport syndrome.


We are targeting the underlying biology of these diseases with a novel and potentially powerful approach: MicroRNA-based therapeutics.